跳至主要内容
临床试验/NCT04946123
NCT04946123已完成不适用

Association of Methimazole With L-carnitine and Selenium in Patients With Hyperthyroidism

Lo.Li.Pharma s.r.l2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年7月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Hyperthyroidism symptoms

研究概览

简要总结

The study aims to investigate the benefits of methimazole treatment in patients with hyperthyroidism, associated with supplementation of L-carnitine and Selenium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of hyperthyroidism requiring therapy with methimazole

排除标准

  • Drug and alcohol abuse;
  • Pregnancy;
  • Medically uncontrolled psychiatric conditions;
  • Interfering therapies (lithium, interferone, TKI, amiodarone)

结局指标

主要结局

Hyperthyroidism symptoms

时间窗: Change from 6-months supplementation QoL at 12 months of intervention (end of study)

Improvement of the patients' quality of life through questionnaire

次要结局

  • TRAb(Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months))
  • TSH(Four time points: baseline; after 3 months of supplementation; after 6 months of supplementation; end of the study (12 months))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验